Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis

Objective: to evaluate the efficacy and safety of the biosimilar etanercept (ETC, Altebrel) in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) in clinical practice.Material and methods. The study included 20 patients with a confirmed diagnosis of RA and 8 with SpA: 5 with axial S...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	B. G. Issayeva, D. S. Dilmanova, A. S. Amanzholova, S. M. Issayeva, A. B. Kanapina, A. E. Turtaeva, G. Sh. Trimova
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	IMA-PRESS LLC 2024-10-01
Saila:	Современная ревматология
Gaiak:	rheumatoid arthritis spondyloarthritis etanercept etanercept bioanalogue altebrel
Sarrera elektronikoa:	https://mrj.ima-press.net/mrj/article/view/1641
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!